Global Health Limited

NSE: MEDANTAHealthcare

Global Health Limited Share Price & Analysis

₹1469.80+3.70%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹1469.80+3.70%
Open
₹1424.30
High
₹1491.80
Low
₹1424.30
Close
₹1469.80
52W High
₹1544.00
52W Low
₹955.00
Volume
470K
Lot Size
1
Sector
Healthcare
Market Cap
₹40K Cr
Face Value
₹2
Large CapNIFTY 500Nifty Midcap 150

Price Chart

Candle
Range

Fundamentals

P/E
69.00
Sector P/E
54.70
P/B
9.55
EPS
₹20.69
ROE
15.20%
ROCE
17.40%
D/E Ratio
0.30
Div Yield
0.03%
Book Value
₹147.00

Strengths

  • Strong return on equity (ROE 15.2%)
  • Efficient capital deployment (ROCE 17.4%)
  • Low debt relative to equity (D/E 0.3x)

Concerns

  • High premium to book value (P/B 9.6x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
1,899
₹4.6L Cr36.15.461620.50.07
DIVISLAB
Divi's Laboratories Limited
9,100
₹2.4L Cr81.114.4216.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
4,857
₹1.8L Cr82.819.5827.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,650
₹1.2L Cr59.113.1321.217.40.88
CIPLA
Cipla Limited
1,385
₹1.1L Cr31.33.2511.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
1,120
₹1.1L Cr234.1621.221.10.38
LAURUSLABS
Laurus Labs Limited
1,840
₹99K Cr90.918.7418.317.80.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

MEDANTA · as of Mar 2026

Promoters33.03%
FII11.76%0.72pp
DII11.93%1.42pp
Public43.28%0.70pp
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters33.05%33.04%33.04%33.04%33.03%33.03%
FII11.36%12.10%12.94%12.21%12.48%11.76%
DII11.15%10.25%10.57%11.11%10.51%11.93%
Public44.45%44.60%43.44%43.64%43.98%43.28%

Corporate Events

Dividend - Re 0.50 Per Share

Dividend13 Aug 2026

To consider and approve the financial results for the period ended Jun 30, 2026

Results29 Jul 2026

To consider and approve the financial results for the quarter and year ended March 31, 2026 and recommendation of final dividend, if any subject to shareholders approval.

Dividend13 May 2026

Dividend - Re 0.50 Per Share

Dividend21 Aug 2025

Latest News

All news

STL Global reports Q1FY26 financial results

*STL Global reports Q1FY26 financial results*. The company has submitted its financial results for the quarter ended June 30, 2026. Key performance numbers and guidance will influence near-term trading sentiment. Investors await details on revenue, profit margins, and order book. 📊 *STOCKS:* $STL | 🏢 *SECTOR:* CapitalMarkets | #HIGHIMPACT #Earnings

NSE Filing13 Aug
High Impact

India's services growth hits six-month high on strong domestic demand

*India's services growth hits six-month high on strong domestic demand.* The S&P Global Services PMI rose to **61.0** in May, the highest since November, driven by robust domestic demand. New orders surged with a sharp increase in business confidence. Output and employment expanded at faster rates. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #HIGHIMPACT #PMI

The Economic Times3 Jun
High Impact

Mastek partners with Innovaccer for AI healthcare push

*Mastek partners with Innovaccer for AI healthcare push.* The collaboration aims to accelerate AI-driven solutions in healthcare. While financial details weren’t disclosed, the strategic move enhances Mastek’s footprint in the global health tech space. **No immediate revenue impact** expected in FY25. 📊 *STOCKS:* $MASTEK | 🏢 *SECTOR:* IT | #MEDIUMIMPACT #Partnership

NSE Filing3 Aug
Medium Impact

Avio appoints Sandeep Pandya to lead global healthcare expansion

*Avio appoints Sandeep Pandya to lead global healthcare expansion.* The move signals a strategic push into international diagnostics markets. Pandya brings **20+ years** of global healthcare experience. This leadership hire aims to scale the company’s footprint in emerging regions. 📊 *STOCKS:* AVIO | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Leadership

NSE Filing17 Jun
Medium Impact

STL Global publishes statutory newspaper notice

*STL Global publishes statutory newspaper notice.* This is a routine compliance requirement under corporate regulations. No financial or operational updates were disclosed. **No material impact** expected on trading or investor sentiment. 📊 *STOCKS:* $STL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #StatutoryNotice

NSE Filing27 Aug
Low Impact

STL Global publishes mandatory newspaper notice

*STL Global publishes mandatory newspaper notice.* This is a routine corporate disclosure filed with the NSE, likely related to statutory requirements or board meeting intimation. No financial or operational details provided. **No immediate market-moving information** revealed. 📊 *STOCKS:* $STLGL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #corporate_filing

NSE Filing14 Aug
Low Impact

STL Global announces date of annual general meeting

*STL Global announces date of annual general meeting*. STL Global Limited has informed about the upcoming annual general meeting (AGM) date. The event will allow shareholders to review annual performance and key corporate matters. No financial or strategic updates were disclosed. 📊 *STOCKS:* STLGLOBAL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AGM

NSE Filing13 Aug
Low Impact

STL Global sets record date for shareholder meeting

*STL Global sets record date for shareholder meeting.* The company has announced **23-Sep-2026** as the record date for its upcoming shareholder meeting. This determines eligibility for participation and voting rights. No financial distribution or immediate business change is indicated. 📊 *STOCKS:* $STLGL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #RecordDate

NSE Filing13 Aug
Low Impact

India's services sector growth hits 4.5-year low in July

*India's services sector growth hits 4.5-year low in July* due to weak domestic and external demand. The S&P Global Services PMI fell to **47.6** in July, down from 51.2 in June, indicating contraction. This signals potential slowdown in broader economic momentum. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #MEDIUMIMPACT #PMI

The Hindu5 Aug
Medium Impact

Global Health publishes statutory newspaper notice

*Global Health publishes statutory newspaper notice.* This is a routine compliance requirement under corporate regulations. No financial or operational impact is expected from this filing. Such notices are standard for public disclosures. 📊 *STOCKS:* $GLOBALH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporate filing

NSE Filing31 Jul
Low Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹1.1K Cr
2.0%
₹1.1K Cr
6.6%
₹1.0K Cr
10.7%
₹931 Cr
1.3%
₹943 Cr
1.5%
₹957 Cr
11.1%
₹861 Cr
6.4%
₹809 Cr
Op. Profit
₹217 Cr
6.1%
₹231 Cr
6.5%
₹247 Cr
9.8%
₹225 Cr
5.5%
₹238 Cr
4.4%
₹228 Cr
22.6%
₹186 Cr
3.9%
₹179 Cr
OPM
19.0%
9.5%
21.0%
12.5%
24.0%
0.0%
24.0%
4.0%
25.0%
4.2%
24.0%
9.1%
22.0%
0.0%
22.0%
Net Profit
₹95 Cr
39.9%
₹158 Cr
0.6%
₹159 Cr
57.4%
₹101 Cr
29.4%
₹143 Cr
9.2%
₹131 Cr
23.6%
₹106 Cr
16.5%
₹127 Cr
EPS (₹)
3.54
39.9%
5.89
0.5%
5.92
56.6%
3.78
28.9%
5.32
9.2%
4.87
23.0%
3.96
16.5%
4.74

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Revenue
₹4.4K Cr
19.4%
₹3.7K Cr
12.7%
₹3.3K Cr
20.8%
₹2.7K Cr
25.1%
₹2.2K Cr
49.8%
₹1.4K Cr
3.5%
₹1.5K Cr
3.0%
₹1.5K Cr
8.4%
₹1.3K Cr
2.8%
₹1.4K Cr
Expenses
₹3.5K Cr
24.0%
₹2.8K Cr
13.8%
₹2.5K Cr
19.0%
₹2.1K Cr
21.3%
₹1.7K Cr
36.7%
₹1.3K Cr
4.5%
₹1.3K Cr
2.0%
₹1.3K Cr
5.3%
₹1.2K Cr
12.7%
₹1.1K Cr
Op. Profit
₹930 Cr
5.0%
₹886 Cr
9.5%
₹809 Cr
27.0%
₹637 Cr
39.1%
₹458 Cr
132.5%
₹197 Cr
2.6%
₹192 Cr
11.6%
₹172 Cr
37.6%
₹125 Cr
58.5%
₹301 Cr
OPM
21.0%
12.5%
24.0%
4.0%
25.0%
4.2%
24.0%
14.3%
21.0%
50.0%
14.0%
7.7%
13.0%
8.3%
12.0%
33.3%
9.0%
59.1%
22.0%
Other Income
₹98 Cr
237.9%
₹29 Cr
61.3%
₹75 Cr
53.1%
₹49 Cr
25.6%
₹39 Cr
25.8%
₹31 Cr
29.5%
₹44 Cr
12.0%
₹50 Cr
2.0%
₹49 Cr
8.9%
₹45 Cr
Interest
₹90 Cr
21.6%
₹74 Cr
11.9%
₹84 Cr
2.3%
₹86 Cr
0.0%
₹86 Cr
17.8%
₹73 Cr
28.1%
₹57 Cr
50.0%
₹38 Cr
35.7%
₹28 Cr
100.0%
₹14 Cr
Depreciation
₹223 Cr
14.9%
₹194 Cr
12.1%
₹173 Cr
15.3%
₹150 Cr
15.4%
₹130 Cr
5.7%
₹123 Cr
7.0%
₹115 Cr
12.7%
₹102 Cr
18.6%
₹86 Cr
22.9%
₹70 Cr
PBT
₹715 Cr
10.5%
₹647 Cr
3.2%
₹627 Cr
39.6%
₹449 Cr
59.8%
₹281 Cr
778.1%
₹32 Cr
50.0%
₹64 Cr
22.9%
₹83 Cr
38.3%
₹60 Cr
77.1%
₹262 Cr
Tax %
23.0%
11.5%
26.0%
8.3%
24.0%
11.1%
27.0%
10.0%
30.0%
172.7%
11.0%
74.4%
43.0%
13.2%
38.0%
15.6%
45.0%
28.6%
35.0%
Net Profit
₹554 Cr
15.2%
₹481 Cr
0.6%
₹478 Cr
46.6%
₹326 Cr
66.3%
₹196 Cr
575.9%
₹29 Cr
19.4%
₹36 Cr
29.4%
₹51 Cr
54.5%
₹33 Cr
80.6%
₹170 Cr
EPS (₹)
20.7
15.5%
17.92
0.6%
17.81
46.5%
12.16
56.9%
7.75
33.4%
5.81
21.1%
7.36
29.5%
10.44
54.0%
6.78
80.7%
35.1
Div Payout
2.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Liabilities
Equity Capital
₹54 Cr
0.0%
₹54 Cr
0.0%
₹54 Cr
0.0%
₹54 Cr
5.9%
₹51 Cr
2.0%
₹50 Cr
2.0%
₹49 Cr
0.0%
₹49 Cr
2.1%
₹48 Cr
0.0%
₹48 Cr
Reserves
₹3.7K Cr
9.6%
₹3.3K Cr
16.9%
₹2.9K Cr
20.1%
₹2.4K Cr
51.8%
₹1.6K Cr
17.4%
₹1.3K Cr
2.5%
₹1.3K Cr
4.3%
₹1.2K Cr
9.7%
₹1.1K Cr
16.4%
₹976 Cr
Borrowings
₹945 Cr
31.6%
₹718 Cr
10.5%
₹802 Cr
28.5%
₹1.1K Cr
1.2%
₹1.1K Cr
19.1%
₹931 Cr
0.2%
₹929 Cr
18.0%
₹787 Cr
72.6%
₹456 Cr
176.4%
₹165 Cr
Other Liabilities
₹757 Cr
14.4%
₹662 Cr
15.7%
₹572 Cr
4.6%
₹547 Cr
29.9%
₹421 Cr
10.8%
₹380 Cr
2.1%
₹388 Cr
11.8%
₹347 Cr
1.2%
₹343 Cr
16.3%
₹295 Cr
Total Liabilities
₹5.4K Cr
13.5%
₹4.8K Cr
11.4%
₹4.3K Cr
4.5%
₹4.1K Cr
30.2%
₹3.1K Cr
16.8%
₹2.7K Cr
1.1%
₹2.7K Cr
9.7%
₹2.4K Cr
22.5%
₹2.0K Cr
33.6%
₹1.5K Cr
Assets
Fixed Assets
₹3.2K Cr
27.2%
₹2.5K Cr
12.4%
₹2.2K Cr
9.1%
₹2.0K Cr
15.4%
₹1.8K Cr
9.9%
₹1.6K Cr
5.1%
₹1.7K Cr
42.6%
₹1.2K Cr
9.1%
₹1.1K Cr
19.7%
₹914 Cr
CWIP
₹318 Cr
40.3%
₹533 Cr
37.4%
₹388 Cr
18.7%
₹327 Cr
25.5%
₹439 Cr
5.4%
₹464 Cr
21.5%
₹382 Cr
42.6%
₹666 Cr
110.1%
₹317 Cr
2541.7%
₹12 Cr
Investments
₹3 Cr
0.0%
₹3 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
Other Assets
₹1.9K Cr
10.1%
₹1.7K Cr
3.6%
₹1.7K Cr
3.7%
₹1.7K Cr
84.9%
₹930 Cr
51.2%
₹615 Cr
5.9%
₹581 Cr
1.9%
₹570 Cr
0.5%
₹573 Cr
2.5%
₹559 Cr
Total Assets
₹5.4K Cr
13.5%
₹4.8K Cr
11.4%
₹4.3K Cr
4.5%
₹4.1K Cr
30.2%
₹3.1K Cr
16.8%
₹2.7K Cr
1.1%
₹2.7K Cr
9.7%
₹2.4K Cr
22.5%
₹2.0K Cr
33.6%
₹1.5K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Operating CF
₹714 Cr
14.4%
₹624 Cr
2.0%
₹612 Cr
5.1%
₹645 Cr
107.4%
₹311 Cr
28.5%
₹242 Cr
38.3%
₹175 Cr
5.4%
₹166 Cr
163.5%
₹63 Cr
72.4%
₹228 Cr
Investing CF
₹-1.1K Cr
51.0%
₹-721 Cr
63.5%
₹-441 Cr
28.9%
₹-342 Cr
18.8%
₹-421 Cr
76.2%
₹-239 Cr
174.7%
₹-87 Cr
65.1%
₹-249 Cr
260.9%
₹-69 Cr
71.4%
₹-241 Cr
Financing CF
₹272 Cr
380.4%
₹-97 Cr
81.1%
₹-514 Cr
248.6%
₹346 Cr
116.3%
₹160 Cr
297.5%
₹-81 Cr
8000.0%
₹-1 Cr
101.0%
₹97 Cr
977.8%
₹9 Cr
228.6%
₹-7 Cr
Net Cash Flow
₹-103 Cr
46.9%
₹-194 Cr
43.4%
₹-343 Cr
152.9%
₹648 Cr
1196.0%
₹50 Cr
164.1%
₹-78 Cr
189.7%
₹87 Cr
521.4%
₹14 Cr
366.7%
₹3 Cr
115.0%
₹-20 Cr
Free Cash Flow
₹-123 Cr
211.8%
₹110 Cr
67.2%
₹335 Cr
18.1%
₹409 Cr
976.3%
₹38 Cr
62.0%
₹100 Cr
869.2%
₹-13 Cr
90.2%
₹-133 Cr
64.2%
₹-81 Cr
214.1%
₹71 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
Debtor Days
34d
17.2%
29d
20.8%
24d
7.7%
26d
13.3%
30d
11.8%
34d
5.6%
36d
12.2%
41d
0.0%
41d
105.0%
20d
Inventory Days
29d
3.6%
28d
12.5%
32d
8.6%
35d
2.8%
36d
14.3%
42d
2.3%
43d
65.4%
26d
0.0%
26d
7.1%
28d
Days Payable
89d
9.9%
81d
10.0%
90d
21.1%
114d
26.7%
90d
34.8%
138d
6.1%
147d
3.5%
142d
14.5%
124d
34.8%
92d
Cash Conv. Cycle
-26d
8.3%
-24d
29.4%
-34d
34.6%
-52d
116.7%
-24d
61.3%
-62d
7.5%
-67d
10.7%
-75d
33.9%
-56d
24.4%
-45d
Working Capital Days
-7d
66.7%
-21d
34.4%
-32d
13.5%
-37d
85.0%
-20d
58.3%
-48d
54.8%
-31d
72.2%
-18d
45.5%
-33d
43.5%
-23d
ROCE
17.0%
15.0%
20.0%
0.0%
20.0%
17.6%
17.0%
13.3%
15.0%
200.0%
5.0%
16.7%
6.0%
0.0%
6.0%

Source: Screener.in · Lower days = better efficiency

Frequently Asked Questions

What is Global Health Limited share price today?
Global Health Limited (MEDANTA) is currently trading at ₹1,469.8 on NSE, up 3.70% as of the last market session. Prices update daily after market close on MarketNetra.
Is Global Health Limited available in F&O (Futures & Options)?
Yes, Global Health Limited (MEDANTA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Global Health Limited 52-week high and low?
Global Health Limited's 52-week high is ₹1,544 and the 52-week low is ₹955. The current price of ₹1,469.8 is 4.8% below the 52W high.
What is Global Health Limited P/E ratio?
Global Health Limited's current P/E ratio is 69. This indicates the market is paying ₹69 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Global Health Limited options?
Global Health Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MEDANTA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.